Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapy
US-12371747-B2 · Jul 29, 2025 · US
This page is not indexed by search engines while we improve data quality.
Pierce Glenn patents
Pierce Glenn is listed as an inventor on 40 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Pierce Glenn |
| Total patents | 40 |
| First publication | Sep 10, 2015 |
| Latest publication | Jul 29, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Factor viii chimeric and hybrid polypeptides, and methods of use thereof
US-2025195620-A1 · Jun 19, 2025 · US
Factor VIII chimeric and hybrid polypeptides, and methods of use thereof
US-12186375-B2 · Jan 7, 2025 · US
Assays to monitor bleeding disorders
US-11747351-B2 · Sep 5, 2023 · US
Methods of reducing immunogenicity against factor viii in individuals undergoing factor viii therapy
US-2023002828-A1 · Jan 5, 2023 · US
Factor viii-fc chimeric and hybrid polypeptides, and methods of use thereof
US-2022265780-A1 · Aug 25, 2022 · US
Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapy
US-11286528-B2 · Mar 29, 2022 · US
Factor VIII-FC chimeric and hybrid polypeptides, and methods of use thereof
US-11266720-B2 · Mar 8, 2022 · US
Methods of using fix polypeptides
US-2022064622-A1 · Mar 3, 2022 · US
Methods of using FIX polypeptides
US-11225650-B2 · Jan 18, 2022 · US
Recent patents
Latest publications not already listed above.
Factor viii chimeric and hybrid polypeptides, and methods of use thereof
US-2021220476-A1 · Jul 22, 2021 · US
Factor ix polypeptides and methods of use thereof
US-2021023185-A1 · Jan 28, 2021 · US
Factor IX polypeptides and methods of use thereof
US-10898554-B1 · Jan 26, 2021 · US
Factor ix polypeptides and methods of use thereof
US-2021008178-A1 · Jan 14, 2021 · US
Factor VIII chimeric and hybrid polypeptides, and methods of use thereof
US-10881742-B2 · Jan 5, 2021 · US
Assays to monitor bleeding disorders
US-2020386774-A1 · Dec 10, 2020 · US
Assays to monitor bleeding disorders
US-10656167-B2 · May 19, 2020 · US
Factor IX polypeptides and methods of use thereof
US-10568943-B2 · Feb 25, 2020 · US
Factor IX polypeptides and methods of use thereof
US-10561714-B2 · Feb 18, 2020 · US
Factor IX polypeptides and methods of use thereof
US-10548954-B2 · Feb 4, 2020 · US
Factor viii-fc chimeric and hybrid polypeptides, and methods of use thereof
US-2019262429-A1 · Aug 29, 2019 · US
Methods of reducing immunogenicity against factor viii in individuals undergoing factor viii therapy
US-2019241960-A1 · Aug 8, 2019 · US
Factor ix polypeptides and methods of use thereof
US-2019192640-A1 · Jun 27, 2019 · US
Factor ix polypeptides and methods of use thereof
US-2019192641-A1 · Jun 27, 2019 · US
Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapy
US-10221455-B2 · Mar 5, 2019 · US
Factor viii chimeric and hybrid polypeptides, and methods of use thereof
US-2018360982-A1 · Dec 20, 2018 · US
Factor IX Polypeptides and Methods of Use Thereof
US-2018228879-A1 · Aug 16, 2018 · US
Factor IX Polypeptides and Methods of Use Thereof
US-2018228878-A1 · Aug 16, 2018 · US
Targeted coagulation factors and method of using the same
US-10035840-B2 · Jul 31, 2018 · US
Factor IX Polypeptides and Methods of Use Thereof
US-2018207244-A1 · Jul 26, 2018 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Bioverativ Therapeutics Inc | 36 |
| Puget Sound Blood Center | 5 |
| Jiang Haiyan | 3 |
| Pierce Glenn | 3 |
| Bayer Healthcare Llc | 3 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P7/04 | 37 |
| C07K2319/30 | 31 |
| A61K47/68 | 27 |
| C12N9/644 | 23 |
| C07K2319/31 | 22 |